Press "Enter" to skip to content

Posts published in “Patent Added”

New patent for Shire Dev drug XIIDRA

0

Annual Drug Patent Expirations for XIIDRA Xiidra is a drug marketed by Shire Dev Llc and is included in one NDA. It is available from one supplier. There are fourteen…

New patent for Leo Pharma drug ENSTILAR

0

Annual Drug Patent Expirations for ENSTILAR Enstilar is a drug marketed by Leo Pharma As and is included in one NDA. It is available from one supplier. There are two…

New patent for Valeant Pharms drug UCERIS

0

Annual Drug Patent Expirations for UCERIS Uceris is a drug marketed by Valeant Pharms Intl and is included in two NDAs. It is available from three suppliers. There are twelve…

New patent for Paratek Pharms drug NUZYRA

0

Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. The generic ingredient in NUZYRA is omadacycline tosylate. Additional…

New patent for Optinose Us drug XHANCE

0

Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are eleven…

New patent for Merck Sharp drug NOXAFIL

0

Annual Drug Patent Expirations for NOXAFIL Noxafil is a drug marketed by Merck Sharp Dohme and Schering and is included in three NDAs. It is available from one supplier. There…

New patent for Cubist Pharms drug ZERBAXA

0

Annual Drug Patent Expirations for ZERBAXA Zerbaxa is a drug marketed by Cubist Pharms Llc and is included in one NDA. It is available from one supplier. There are seven…

Do NOT follow this link or you will be banned from the site!